| （単位：千ドル） | 2019/3 | 2020/3 | 2021/3 | 2022/3 | 2023/3 | 2024/3 | 2025/3 |
|---|---|---|---|---|---|---|---|
| 研究開発費 | 22,173 | 38,761 | 56,754 | 79,545 | 126,527 | 174,963 | 189,447 |
| 営業費用 | 30,946 | 56,198 | 79,955 | 118,314 | 177,080 | 234,773 | 261,627 |
| 営業利益 | -30,946 | -56,198 | -79,955 | -118,314 | -177,080 | -234,773 | -261,627 |
| 経常（税引前）利益 | - | - | - | - | -173,996 | -215,386 | -246,829 |
| 法人税等合計 | - | - | - | - | 300 | 400 | 500 |
| 実効税率（％） | - | - | - | - | -0.2 | -0.2 | -0.2 |
| 純利益 | 30,834 | -52,625 | -80,870 | -118,036 | -174,284 | -215,794 | -247,297 |
| 一株あたり利益 | - | - | - | -2.26 | -2.99 | -3.24 | -3.07 |
| 希薄化後一株あたり利益 | - | - | - | -2.26 | -2.99 | -3.24 | -3.07 |
| EBITDA | -78,255 | -116,214 | -174,680 | -232,073 | -258,127 |